Investor Presentation: Q3 & 9MFY2024 slide image

Investor Presentation: Q3 & 9MFY2024

Liquids: Continued Growth 450 Revenue 400 350 300 ã…Ž 250 270 234 208 200 183 Rs. 150 100 50 0 FY19 FY20 FY21 FY22 FY23 INVESTOR PRESENTATION: Q3 & 9MFY2024 300 418 Rs. in Cr. 250 200 150 104 100 50 FY19 EBIDTA* 195 173 137 FY20 FY21 FY22 FY23 *Normalized EBITDA: before Forex, hedging-related expenses 272 AEGIS 19
View entire presentation